These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 10547559

  • 21. Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
    Costello RT, Zerazhi H, Charbonnier A, de Colella JM, Alzieu C, Poizot-Martin I, Cohen R, Bardou VJ, Xerri L, Olive D, Nezri M, Lepeu G, Gastaut JA.
    Cancer; 2004 Feb 15; 100(4):667-76. PubMed ID: 14770420
    [Abstract] [Full Text] [Related]

  • 22. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, Forman SJ.
    Cancer; 2000 Aug 01; 89(3):680-9. PubMed ID: 10931469
    [Abstract] [Full Text] [Related]

  • 23. Liposomal doxorubicin, cyclophosphamide, and etoposide and antiretroviral therapy for patients with AIDS-related lymphoma: a pilot study.
    Combs S, Neil N, Aboulafia DM.
    Oncologist; 2006 Jun 01; 11(6):666-73. PubMed ID: 16794245
    [Abstract] [Full Text] [Related]

  • 24. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.
    Haematologica; 2000 Feb 01; 85(2):160-6. PubMed ID: 10681723
    [Abstract] [Full Text] [Related]

  • 25. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C, Taylor TH, Aboumrad T, Anton-Culver H.
    Cancer; 2006 Jan 01; 106(1):128-35. PubMed ID: 16329140
    [Abstract] [Full Text] [Related]

  • 26. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
    Singhal D, Witham TF, Germanwala A, Flickinger JC, Schiff D, Kondziolka D.
    Can J Neurol Sci; 2002 May 01; 29(2):147-53. PubMed ID: 12035835
    [Abstract] [Full Text] [Related]

  • 27. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma.
    Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Viganò MG, Guidoboni M, Dolcetti R, McKenna RW, Facchetti F.
    Mod Pathol; 2002 Dec 01; 15(12):1273-8. PubMed ID: 12481007
    [Abstract] [Full Text] [Related]

  • 28. Late-delayed cerebral involvement in systemic non-Hodgkin lymphoma: a second primary tumor or a tardy recurrence?
    Lossos A, Ashhab Y, Sverdlin E, Amir G, Ben-Yehuda D, Siegal T.
    Cancer; 2004 Oct 15; 101(8):1843-9. PubMed ID: 15372481
    [Abstract] [Full Text] [Related]

  • 29. Secondary central nervous system involvement by follicular lymphoma: case report and review of the literature.
    Grupka NL, Seinfeld J, Ryder J, Lillehei KO, Kleinschmidt-Demasters BK.
    Surg Neurol; 2006 Jun 15; 65(6):590-4. PubMed ID: 16720183
    [Abstract] [Full Text] [Related]

  • 30. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B, German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL).
    Cancer; 2006 Jan 01; 106(1):136-45. PubMed ID: 16331635
    [Abstract] [Full Text] [Related]

  • 31. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb 01; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 32. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
    Hänel M, Kröger N, Sonnenberg S, Bornhäuser M, Krüger W, Kroschinsky F, Hänel A, Metzner B, Birkmann J, Schmid B, Hoffknecht MM, Fiedler F, Ehninger G, Zander AR.
    Ann Hematol; 2002 Feb 01; 81(2):96-102. PubMed ID: 11907790
    [Abstract] [Full Text] [Related]

  • 33. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
    Levine AM, Tulpule A, Espina B, Sherrod A, Boswell WD, Lieberman RD, Nathwani BN, Welles L.
    J Clin Oncol; 2004 Jul 01; 22(13):2662-70. PubMed ID: 15226333
    [Abstract] [Full Text] [Related]

  • 34. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD.
    Cancer; 2003 Sep 01; 98(5):1021-8. PubMed ID: 12942571
    [Abstract] [Full Text] [Related]

  • 35. Intrathecal chemotherapy in lymphomatous meningitis.
    Canova F, Marino D, Trentin C, Soldà C, Ghiotto C, Aversa SM.
    Crit Rev Oncol Hematol; 2011 Aug 01; 79(2):127-34. PubMed ID: 20696592
    [Abstract] [Full Text] [Related]

  • 36. [Primary non-Hodgkin's malignant lymphoma of the central nervous system].
    Monjour A, Poisson M, Kujas M, Delattre JY.
    Rev Neurol (Paris); 1992 Aug 01; 148(10):589-600. PubMed ID: 1295053
    [Abstract] [Full Text] [Related]

  • 37. Clinical manifestations and treatment of HIV related non-Hodgkin lymphoma.
    Northfelt DW, Kaplan LD.
    Cancer Surv; 1991 Aug 01; 10():121-33. PubMed ID: 1821318
    [Abstract] [Full Text] [Related]

  • 38. Involvement of the central nervous system by non-Hodgkin's lymphoma in adults. A review of 36 cases.
    Mead GM, Kennedy P, Smith JL, Thompson J, Macbeth FR, Ryall RD, Williams CJ, Whitehouse JM.
    Q J Med; 1986 Jul 01; 60(231):699-714. PubMed ID: 3763820
    [Abstract] [Full Text] [Related]

  • 39. Intraocular lymphoma: report of three cases and review of the literature.
    Trudeau M, Shepherd FA, Blackstein ME, Gospodarowicz M, Fitzpatrick P, Moffatt KP.
    Am J Clin Oncol; 1988 Apr 01; 11(2):126-30. PubMed ID: 3282423
    [Abstract] [Full Text] [Related]

  • 40. [Diagnosis, prophylaxis and treatment of central nervous system involvement by non-Hodgkin lymphoma in HIV-infected patients].
    Miralles P, Berenguer J, Ribera JM, grupo de estudio de la afección del sistema nervioso central en linfomas asociados a la infección por el virus de la inmunodeficiencia.
    Med Clin (Barc); 2010 Sep 18; 135(9):417-22. PubMed ID: 19628233
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.